Published 2021 | Version v1
Journal article

Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients. A prospective multicenter study

  • 1. Universitätsklinikum Erlangen, Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Medizinische Klinik 1, Erlangen (Germany)
  • 2. Universitätsklinikum Regensburg, Regensburg (Germany)
  • 3. Diakonissenkrankenhaus Dresden, Dresden (Germany)
  • 4. Universitätsklinikum Bonn, Bonn (Germany)
  • 5. Universitätsklinikum Magdeburg, Magdeburg (Germany)
  • 6. Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim (Germany)
  • 7. Klinikum Ludwigsburg, Ludwigsburg (Germany)
  • 8. Universitätsklinikum Freiburg, Freiburg (Germany)
  • 9. Universitätsklinikum Erlangen, Medizinische Klinik 1, Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen (Germany)

Description

Hepatocellular carcinoma (HCC) can be diagnosed non-invasively with contrast-enhanced ultrasound (CEUS) in cirrhosis if the characteristic pattern of arterial phase hyperenhancement followed by hypoenhancement is present. Recent studies suggest that diagnosis based on this ''hyper-hypo'' pattern needs further refinement. This study compares the diagnostic accuracies of standardized CEUS for HCC according to the current guideline definition and following the newly developed CEUS algorithms (CEUS LI-RADS®, ESCULAP) in a prospective multicenter real-life setting. Cirrhotic patients with liver lesions on B-mode ultrasound were recruited prospectively from 04/2018 to 04/2019, and clinical and imaging data were collected. The CEUS standard included an additional examination point after 4-6 min in case of no washout after 3 min. The diagnostic accuracies of CEUS following the guidelines (''hyper-hypo'' pattern), based on the examiner's subjective interpretation (''CEUS subjective''), and based on the CEUS algorithms ESCULAP and CEUS LI-RADS® were compared. In total, 470 cirrhotic patients were recruited in 43 centers. The final diagnosis was HCC in 378 cases (80.4%) according to the reference standard (histology 77.4%, MRI 16.4%, CT 6.2%). The ''hyper-hypo'' pattern yielded 74.3% sensitivity and 63% specificity. ''CEUS subjective'' showed a higher diagnostic accuracy (sensitivity, 91.5%; specificity, 67.4%; positive predictive value, 92%; negative predictive value, 66%). Sensitivity was higher for ESCULAP (95%) and ''CEUS subjective'' (91.5%) versus CEUS LI-RADS® (65.2%; p < 0.001). Specificity was highest for CEUS LI-RADS® (78.6%; p < 0.001). CEUS has an excellent diagnostic accuracy for the non-invasive diagnosis of HCC in cirrhosis. CEUS algorithms may be a helpful refinement of the ''hyper-hypo'' pattern defined by current HCC guidelines.

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00330-021-07872-3

Additional details

Identifiers

Publishing Information

Journal Title
European Radiology (Internet)
Journal Volume
31
Journal Issue
10
Journal Page Range
p. 7614-7625
ISSN
1432-1084
CODEN
EURAE3